SynAct Pharma AB (8F8) Q2 2026 Earnings Report
DE:8F8 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.04
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.05
DE:8F8 Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/20/2026
- Time
- TBA
- Conference Call
- Thursday, August 20, 2026
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8F8 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 03, 2026 | 2026 (Q3) | ―- | -0.06 | ― | |
| Aug 20, 2026 | 2026 (Q2) | ―-0.04 | -0.05 | 30.25% (+0.02) | |
| May 27, 2026 | 2026 (Q1) | ―-0.04 | -0.05 | 6.30% (+0.00) | |
| Feb 18, 2026 | 2025 (Q4) | ―-0.04 | -0.04 | 2.27% (+0.00) | |
| Oct 30, 2025 | 2025 (Q3) | ―-0.06 | -0.04 | -37.20% (-0.02) | |
| Aug 20, 2025 | 2025 (Q2) | ―-0.05 | -0.04 | -20.09% (-0.01) | |
| May 27, 2025 | 2025 (Q1) | ―-0.05 | -0.06 | 26.80% (+0.02) | |
| Feb 18, 2025 | 2024 (Q4) | ―-0.04 | -0.23 | 82.80% (+0.19) | |
| Oct 30, 2024 | 2024 (Q3) | ―-0.04 | -0.09 | 50.45% (+0.05) | |
| Aug 20, 2024 | 2024 (Q2) | ―-0.04 | -0.12 | 65.54% (+0.08) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
